Results 141 to 150 of about 12,907 (206)

Prognostic Impact of DPP4 Inhibitors on Systemic Drug Therapy for Advanced Kidney Cancer Patients. [PDF]

Cancer Sci
Kamada S, Kitayama S, Yamase R, Ikeda K, Sato W, Sazuka T, Takeshita H, Sakamoto S, Yano A, Horie K, Ichikawa T, Kawakami S, Inoue S.   +12 more
europepmc   +1 more source

In Silico and In Vitro Evaluation of Bioactive Constituents Isolated from <i>Ziziphus oxyphylla</i> for the Treatment of Diabetes. [PDF]

Biomolecules
Zia-Ul-Haq M, Kaleem WA, Farhana SA, Shah SUA, Rehman A, Khan S, Naz I.   +6 more
europepmc   +1 more source

Outcomes of oral antidiabetic drugs in metabolic dysfunction-associated steatotic liver disease: a nationwide target trial emulation study. [PDF]

Clin Mol Hepatol
Jang H, Kim Y, Lim YK, Lee DH, Joo SK, Koo BK, Kim GA, Lee W, Romeo S, Kim W, Innovative Target Exploration of NAFLD (ITEN) consortium.   +10 more
europepmc   +1 more source

Risk of acute pancreatitis with DPP-4 inhibitors versus SGLT2 inhibitors in medication-naïve individuals with diabetes: A target trial emulation. [PDF]

Diabetes Obes Metab
Tatewaki T, Okada A, Kimura Y, Yasunaga H.   +3 more
europepmc   +1 more source

Cardiovascular and renal outcomes of sodium-glucose cotransporter-2 versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes post-PCI: a meta-analysis of 14,511 patients. [PDF]

Diabetol Metab Syndr
Badran AS, Gbreel MI, Tawfik AM, Balata M.   +3 more
europepmc   +1 more source

Clinical Outcomes with the Use of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Among Patients with Diabetes Mellitus and COVID-19: A Systematic Review of Observational Studies. [PDF]

J Clin Med
Alkhalifah SA, Alshahrani WA, Alshehri AM, Al Yami MS.   +3 more
europepmc   +1 more source

Techniques for the determination of dipeptidyl peptidase IV and screening of its inhibitors. [PDF]

J Pharm Anal
Ma HH, Li XD, Qian XK, Zou LW.
europepmc   +1 more source

Glucagon-Like Peptide 1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, and Risk of Autoimmune Rheumatic Diseases. [PDF]

Arthritis Rheumatol
Karacabeyli D, Lacaille D, Lu N, Xie H, Aviña-Zubieta JA.   +4 more
europepmc   +1 more source

Comparative effects of second-line oral antidiabetic medications on atrial fibrillation risk in patients with type 2 diabetes: a nationwide retrospective cohort study. [PDF]

Cardiovasc Diabetol
Heo GY, Heo SJ, Ko B, Ko YE, Koh HB, Park CH, Park JT, Han SH, Yoo TH, Kang SW, Han M, Kim HW.   +11 more
europepmc   +1 more source

The Caenorhabditis elegans DPF-3 and human DPP4 have tripeptidyl peptidase activity. [PDF]

FEBS Lett
Trivedi A, Gudipati RK.
europepmc   +1 more source